Individual ketoreductase (KR) domains control the ultimate stereochemistry of the vast majority of both hydroxyl- and methyl-bearing stereocenters in the wide array of chemically complex and medicinally important polyketides produced by multimodular polyketide synthases (PKSs) (Figure [1](#fig1){ref-type="fig"}).^[@ref1]−[@ref3]^ Intriguingly, many PKSs also contain one or more modules that harbor redox-inactive homologues of KR domains (Figures [1](#fig1){ref-type="fig"} and [S1](#notes-1){ref-type="notes"}) whose actual biochemical function has long been an enigma.^[@cit2d],[@ref3],[@ref4]^ While in theory such redox-inactive KR^0^ domains might represent mere artifacts resulting from gene duplication of a primordial precursor module with subsequent loss of ketoreductase function,^[@ref5]^ we sought to test the hypothesis that they have a specific catalytic function.

![Roles of redox active (EryKR1 and EryKR6) and redox-inactive (EryKR3° and PicKR3°) KR domains in biosynthesis of typical macrolide aglycones **1** and **2**.](ja-2014-056998_0001){#fig1}

EryKR3^0^ is derived from module 3 of the 6-deoxyerythronolide B (**1**) synthase (DEBS), which generates an unreduced 2-methyl-3-ketoacyl-ACP tetraketide intermediate that is the source of the ultimately derived (8*S*)-8-methyl-9-keto substructure of the eventually formed macrolide aglycone **1** (Figure [1](#fig1){ref-type="fig"}).^[@ref3]^ Since the EryKS3 domain of DEBS module 3 initially generates an unepimerized (2*R*)-2-methyl-3-ketoacyl-ACP intermediate,^[@cit6a]^ formation of the actual (2*S*)-2-methyl-3-ketoacyl-ACP product by DEBS module 3 requires epimerization of the 2-methyl group at some as yet undefined stage. Similarly, the orthologous PicKR3^0^ domain from module 3 of the closely related picromycin synthase^[@ref7]^ is responsible for the analogous (8*S*)-8-methyl-9-keto substructure of the narbonolide aglycone (**2**) (Figure [1](#fig1){ref-type="fig"}), suggesting the need for an epimerase activity in this module as well.^[@cit2d]^ Indeed, a survey of PKS sequences reveals that modules harboring redox-inactive KR^0^ domains are strongly correlated with the presence of a presumptively epimerized (*S*)-α-methyl ketone substructure in the final macrolide or polyether ([Figure S1](#notes-1){ref-type="notes"}).^[@cit2b],[@cit2d]^ We now report experiments demonstrating that both EryKR3^0^ and PicKR3^0^ harbor the heretofore cryptic but nonetheless essential catalytic epimerase function. Our results also rule out any role for the NADPH cofactor in KR-catalyzed epimerization.

We recently described an equilibrium isotope exchange (EIX) assay that provided the first unambiguous proof of the intrinsic epimerase activity of specific PKS ketoreductase domains.^[@ref8]^ The assay exploits the reversibility of the KR-catalyzed reductase-dehydrogenase reaction for the controlled transient oxidative generation of configurationally labile (2*R*)- or (2*S*)-2-methyl-3-ketoacyl-ACP derivatives (**4**) from the corresponding reduced, configurationally stable, \[2-^2^H\]-2-methyl-3-hydroxypentanoyl-ACP thioesters (**3**) (Scheme [1](#sch1){ref-type="scheme"}). For example, incubation of \[2-^2^H\]-(2*S*,3*R*)-**3a** with the epimerizing KR domain EryKR1 in the presence of a catalytic amount of NADP^+^ results in first-order time- and cofactor-dependent washout of deuterium from **3a**, as a consequence of reversible EryKR1-catalyzed epimerization of the derived \[2-^2^H\]-2-methyl-3-ketopentanoyl-ACP (**4**). The exchange of deuterium is conveniently monitored by LC-ESI(+)-MS-MS observation of the pantetheinate ejection fragment **5** derived from recovered **3a** (Scheme [1](#sch1){ref-type="scheme"}c).^[@ref9]^ By contrast, incubation of \[2-^2^H\]-(2*R*,3*S*)-**3b** with EryKR6 and catalytic NADP^+^ does not result in any significant washout of deuterium over a period of more than 1 h, as expected for a nonepimerizing KR domain. The EIX assay has been used to verify the presence or absence of intrinsic epimerase activity in a variety of redox active KR domains.^[@ref8]^

![Equilibrium Isotope Exchange (EIX) Assay](ja-2014-056998_0003){#sch1}

The original EIX assay is not suitable for analysis of redox-inactive KR^0^ domains due to the essential requirement that the reduced, epimerization-inert 2-methyl-3-hydroxyacyl-ACP substrate **3** first undergo reversible oxidization so as to generate transiently the epimerizable 2-methyl-3-ketoacyl-ACP intermediate **4**. (The intermediate **4** cannot simply be prepared and utilized as a substrate due to its propensity to undergo rapid buffer-catalyzed exchange.) We have therefore modified and extended the original EIX assay in order to allow detection and monitoring of the proposed epimerase activity of redox-inactive KR domains.

Tandem EIX utilizes a coupled enzyme assay in which the redox-active, epimerase-inactive EryKR6 domain is used to generate *in situ* the substrate for a redox-silent KR^0^ domain (Scheme [2](#sch2){ref-type="scheme"}).^[@ref10]^ Thus, incubation of equimolar concentrations (75 μM, 11.25 nmol) of EryKR3^0^ and EryKR6 with a 4-fold excess of \[2-^2^H\]-(2*R*,3*S*)-**3b** (300 μM, 45 nmol), in which the labeled diketide is tethered to EryACP6, in the presence of catalytic NADP^+^ (15 μM, 2.25 nmol, 0.05 equiv) at rt in pH 7.2 phosphate buffer resulted in the loss of up to 30% of the original deuterium label from **3b** after 1 h, as established by LC-ESI(+)-MS-MS analysis of the derived pantetheinate ejection fragments at *m*/*z* 376 (d~1~) and 375 (d~0~). Withdrawal of periodic aliquots from the incubation reaction and LC-MS-MS analysis revealed a small but reproducible initial lag time of ∼15 min followed by time-dependent loss of the deuterium label, as evidenced by the plots of the log(% residual deuterium) vs time for the linear phase of the exchange (Table [1](#tbl1){ref-type="other"}, Figure [2](#fig2){ref-type="fig"}a). In a control incubation, less than 5% isotope exchange was observed over 1 h in the absence of EryKR3^0^, as previously reported for EryKR6 alone.^[@ref8]^ Doubling the proportion of NADP^+^ cofactor resulted in a ca. 25% increase in both the first-order rate of deuterium exchange and the total amount of isotope loss (38%) after 1 h, while shortening the apparent lag time to less than 10 min. Doubling the concentration of EryKR3^0^ protein, on the other hand, resulted in a more modest 10% increase in total deuterium exchange. These observations are all consistent with rate-determining EryKR6-catalyzed oxidation of deuterated ACP-bound diketide **3b**, followed by more rapid EryKR3^0^-catalyzed epimerization and consequent exchange of deuterium from the transiently released 2-methyl-3-ketoacyl-ACP intermediate **4**. The observed lag time most likely reflects the time required for the concentration of this EryKR6-bound oxidation product to reach steady state.^[@ref11]^ The combined results unambiguously establish that the redox-inactive EryKR3^0^ has intrinsic epimerase activity. Application of the tandem EIX assay to PicKR3^0^ established that this redox-inactive domain also possesses cryptic epimerase activity (Scheme [2](#sch2){ref-type="scheme"}, Table [1](#tbl1){ref-type="other"}, Figure [2](#fig2){ref-type="fig"}a).

![Tandem EIX Assay of Redox-Inactive KR^0^ Domains](ja-2014-056998_0004){#sch2}

###### Tandem EIX Assay of Redox-Inactive KR^0^ domains

                                                                                  time (min)                               
  ------------------------------------------------------------------------------- ------------ --- --- ---- ---- ---- ---- ----
  EryKR3^0 ^[b](#t1fn2){ref-type="table-fn"}                                      0            0   0   11   13   21   25   30
  EryKR3^0 ^[c](#t1fn3){ref-type="table-fn"}                                      0            5   7   13   16   30   36   38
  EryKR3^0^[b](#t1fn2){ref-type="table-fn"}^,^[d](#t1fn4){ref-type="table-fn"}    0            0   7   13   16   23   29   33
  PicKR3^0 ^[b](#t1fn2){ref-type="table-fn"}                                      0            0   0   14   20   24   27   27
  EryKR1-pG[b](#t1fn2){ref-type="table-fn"}                                       0            0   4   9    17   24   25   29
  EryKR1-eG[b](#t1fn2){ref-type="table-fn"}                                       0            0   7   11   13   16   19   22
  EryKR1-eGeL[b](#t1fn2){ref-type="table-fn"}                                     0            0   5   12   14   16   18   21
  EryKR1-eL[b](#t1fn2){ref-type="table-fn"}                                       0            0   0   5    9    9    11   13
                                                                                                                            
  EryKR3^0 ^[b](#t1fn2){ref-type="table-fn"}^,^[e](#t1fn5){ref-type="table-fn"}   0            0   5   12   16   22   29   34
  PicKR3^0 ^[b](#t1fn2){ref-type="table-fn"}^,^[e](#t1fn5){ref-type="table-fn"}   0            0   4   11   19   24   27   31

Average of two or more measurements (±2%.).

0.0.05 equiv of NADP^+^

0.0.1 equiv of NADP^+^.

0.2 equiv of EryKR3^0^.

TylKR1 and \[2-^2^H\]-**3c** in place of EryKR6 and **3b**.

![Time-dependent tandem EIX washout of deuterium from \[2-^2^H\]-**3b**. (a) Redox-inactive EryKR3^0^ or PicKR3^0^. (b) Redox-inactive EryKR1^0^ mutants.](ja-2014-056998_0002){#fig2}

As expected, the presence of a *redox-inactive* but *epimerase-active* KR^0^ domain in the tandem EIX assay does not alter the stereochemistry of the recovered reduced diketide substrate.^[@ref12]^ Separate control incubations of \[2-^2^H\]-(2*R*,3*S*)-**3b** with either EryKR3^0^ or PicKR3^0^ plus EryKR6 in the presence of catalytic NADP^+^ (0.05 equiv) were performed for 20 min in pH 7.2 phosphate. After quenching with aq. base and 20 min of hydrolysis at 65 °C followed by treatment with trimethylsilyldiazomethane, the resultant methyl ester was shown by chiral GC-MS to be diastereomerically pure methyl (2*R*,3*S*)-2-methyl-3-hydroxypentanoate ([Figure S6](#notes-1){ref-type="notes"}).

To further test the generality of the tandem EIX assay, we carried out analogous incubations using the redox-active, epimerase-inactive^[@ref8]^ TylKR1 and its cognate substrate,^[@ref6]^ (2*R*,3*R*)-\[2-^2^H\]-**3c**, in place of EryKR6 and (2*R*,3*S*)-\[2-^2^H\]-**3b** (Scheme [2](#sch2){ref-type="scheme"}b). The results with both EryKR3^0^ and PicKR3^0^ showed comparable rates and end points of deuterium exchange compared to those obtained with EryKR6 (Table [1](#tbl1){ref-type="other"}). No exchange was observed in the absence of the requisite KR^0^ domain. The tandem EIX assay is therefore not restricted to the use of a single redox-active KR domain.

In order to probe further the epimerization mechanism, we also disrupted the NADPH binding site of EryKR1 so as to produce redox-inactive forms. We wished to test whether these mutants still retained the intrinsic epimerase activity of the wild-type enzyme. Multiple sequence alignments of 5 redox-inactive KR domains, including EryKR3^0^ and PicKR3^0^, and comparison with the NADPH-binding regions of 16 redox active domains identified 3 conserved motifs within each of the 4 stereochemical classes of redox-active KR domains that are absent in the corresponding regions of redox-inactive KR^0^ domains ([Figure S2](#notes-1){ref-type="notes"}). These differences are also supported by direct superposition of the structures of EryKR1 and PicKR3^0^, while reinforcing previous structural analysis of the defect in NADPH binding in redox inactive KR domains.^[@cit2d]^

The method of overlap extension PCR^[@ref13]^ was used to generate a candidate set of four redox inactive EryKR1° mutants: (1) EryKR1^0^-eG, in which the conserved **G**T**G**GV**G** motif of EryKR1 has been replaced by the corresponding AASPV**G** sequence from EryKR3^0^; (2) EryKR1^0^-pG, in which this same motif has been replaced by the corresponding AEEPAA sequence from PicKR3^0^; (3) EryKR1^0^-eL in which the conserved **VSRSGPDA**D**GA**G**E** linker from EryKR1 is replaced by AGACPGDD from EryKR3^0^; and (4) a double mutant, EryKR1^0^-eGeL, containing both the eG and eL swaps. None of the four EryKR1^0^ mutants bound NADPH, as determined by fluorescence enhancement assay ([Figure S4](#notes-1){ref-type="notes"}),^[@ref14]^ and all four were devoid of residual ketoreductase activity when incubated with the standard KR assay substrate 1-decalone ([Figure S5](#notes-1){ref-type="notes"}).^[@ref14]^

Analysis by tandem EIX assay of the four redox-inactive EryKR1^0^ mutants that could no longer bind NADPH confirmed that all retained the intrinsic epimerase activity of wild-type EryKR1 (Table [1](#tbl1){ref-type="other"}, Figure [2](#fig2){ref-type="fig"}b). Thus, incubation of EryKR1-pG plus EryKR6 with \[2-^2^H\]-**3b** and 0.05 equiv NADP^+^ resulted in deuterium exchange that was essentially identical to that measured for EryKR3^0^ or PicKR3^0^ under the same conditions, but with a small reduction in the apparent lag time. EryKR1-eG and the double mutant EryKR1-eGeL each showed only slightly lower levels of deuterium washout, while the EryKR1-eL loop-swap mutant showed 2--2.5-fold reduced but nonetheless significant rates of equilibrium isotope exchange compared to EryKR3^0^.

As demonstrated for EryKR1, it should now be possible to suppress the intrinsic redox activity of any epimerase-active PKS KR domain by rational abolition of the natural NADPH binding site while retaining the native epimerase activity. The demonstration that epimerase activity in both redox-active and redox-inactive KR domains does not require NADPH firmly excludes a recent suggestion that KR-catalyzed epimerization occurs by conjugate addition of NADPH to the enol-ester tautomer of the 2-methyl-3-ketoacyl-ACP substrate.^[@ref15]^ The path is also now open to further systematic modifications of native or engineered redox-inactive, epimerase-active KR^0^ domains in order to establish the protein structural basis for catalysis of the biosynthetically critical but mechanistically still mysterious KR-catalyzed epimerization reaction itself.

Experimental methods, including mutant design, construction, and characterization, and details of tandem EIX assay. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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